TY - JOUR
T1 - Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands
AU - Ramachandran, Sarika M.
AU - Leventhal, Jonathan S.
AU - Franco, Loren G.
AU - Mir, Adnan
AU - Walters, Ruth F.
AU - Franks, Andrew G.
N1 - Funding Information:
Funding The Frances and Benjamin Benenson Foundation and Lynn and William M. Silverman Donation Fund.
PY - 2017/1
Y1 - 2017/1
N2 - Subacute cutaneous lupus erythematosus (SCLE) is a well-defined subtype of lupus erythematosus, characterised by photosensitivity, annular and/or psoriasiform lesions, variable systemic involvement and presence of circulating SSA/anti-Ro antibodies. SCLE may be idiopathic or drug-induced. Both the idiopathic and drug-induced forms of SCLE are analogous in their clinical, serological and histological features. Drug-induced SCLE has been reported with various oral agents, but to our knowledge this is the first reported case due to a topical medication. A 34-year-old female foot masseuse presented with a 2-month history of scaly, erythematous lesions isolated to the dorsal hands and interdigital spaces. She had used topical terbinafine, a topical antifungal cream, to her clients' feet for a number of years. ANA and anti-SSA/Ro antibodies were positive. Physical examination, serology and histopathology were consistent with SCLE. We propose that our patient's unique presentation of SCLE may be explained by a prolonged occupational exposure to topical terbinafine as a foot masseuse. While oral terbinafine is a drug known to cause drug-induced SCLE, to our knowledge, this is the first topically induced form of the disease.
AB - Subacute cutaneous lupus erythematosus (SCLE) is a well-defined subtype of lupus erythematosus, characterised by photosensitivity, annular and/or psoriasiform lesions, variable systemic involvement and presence of circulating SSA/anti-Ro antibodies. SCLE may be idiopathic or drug-induced. Both the idiopathic and drug-induced forms of SCLE are analogous in their clinical, serological and histological features. Drug-induced SCLE has been reported with various oral agents, but to our knowledge this is the first reported case due to a topical medication. A 34-year-old female foot masseuse presented with a 2-month history of scaly, erythematous lesions isolated to the dorsal hands and interdigital spaces. She had used topical terbinafine, a topical antifungal cream, to her clients' feet for a number of years. ANA and anti-SSA/Ro antibodies were positive. Physical examination, serology and histopathology were consistent with SCLE. We propose that our patient's unique presentation of SCLE may be explained by a prolonged occupational exposure to topical terbinafine as a foot masseuse. While oral terbinafine is a drug known to cause drug-induced SCLE, to our knowledge, this is the first topically induced form of the disease.
UR - http://www.scopus.com/inward/record.url?scp=85033787477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033787477&partnerID=8YFLogxK
U2 - 10.1136/lupus-2017-000207
DO - 10.1136/lupus-2017-000207
M3 - Article
C2 - 28331627
AN - SCOPUS:85033787477
SN - 2053-8790
VL - 4
JO - Lupus Science and Medicine
JF - Lupus Science and Medicine
IS - 1
M1 - e000207
ER -